NeoMatrix Therapeutics
NY - Stony BrookBiotechnology
Focus: NeoMatrix Therapeutics is a public biotech company focused on bioactive peptides for burn wound healing, headquartered in Stony Brook, NY. The company operates in a highly specialized niche with a focused pipeline targeting thermal and acute burn indications.
Profile data last refreshed 6h ago · AI intelligence enriched 1mo ago
Funding Stage
PUBLIC
Open Jobs
0
About NeoMatrix Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow NeoMatrix Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from NeoMatrix Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
cNP8
BurnsClinical Trials (1)
NCT06223009Phase 1 Healthy Volunteer Burn Therapy Study
Phase 1Help build intelligence for NeoMatrix Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.